Stopping warfarin therapy is unnecessary for hand surgery

Journal of Hand Surgery

Volumn 29 B, Issue 3, 2004, Pages 203-205

  Wallace, D L ^a   Latimer, M D ^a   Belcher, H J C R ^a  

^a QUEEN VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Anticoagulants; Hand surgery; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INDICATION; FEMALE; HAND SURGERY; HEART ATRIUM FIBRILLATION; HEART VALVE REPLACEMENT; HEMOSTASIS; HUMAN; INTERNATIONAL STANDARD UNIT; INTRAOPERATIVE PERIOD; MALE; POSTOPERATIVE HEMORRHAGE; VENOUS THROMBOEMBOLISM;

EID: 2542522179     PISSN: 02667681     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhsb.2003.12.008     Document Type: Article

References (28)

1. Alcalay J (2001). Cutaneous surgery in patients receiving warfarin therapy. Dermatological Surgery and Oncology, 27: 756-758.
2. Blacker DJ, Wijdicks EFM, McClelland RL (2003). Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology, 61: 964-968.
3. British Thoracic Society (1992). Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society. Lancet, 340: 873-876.
4. Dunn AS, Turpie AGG (2003). Perioperative management of patients receiving oral anticoagulants. A systematic review. Archives of Internal Medicine, 163: 901-908.
5. Ebskov LB, Boeckstyns MEH. Sørensen AI, Haugegaard M (1997). Day care surgery for advanced Dupuytren's contracture. Journal of Hand Surgery, 22B: 191-192.
6. European Atrial Fibrillation Trial Study Group (1993). Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet, 342: 1255-1262.
7. Gainey SP, Robertson DM, Fay W, Ilstrup D (1989). Ocular surgery on patients receiving long-term warfarin therapy. American Journal of Ophthalmology, 108: 142-146.
8. Gelberman RH, Panagis JS, Hergenroeder PT, Zakaib GS (1982). Wound complications in the surgical management of Dupuytren's contracture: a comparison of operative incisions. Hand, 14: 248-254.
9. Haemostasis and Thrombosis Task Force of the British Society of Haematology (1998). Guidelines on oral anticoagulation: third edition. British Journal of Haematology, 101: 374-387.
10. Hall DL, Steen Jr WH, Drummond JW, Byrd WA (1988). Anticoagulants and cataract surgery. Ophthalmic surgery, 19: 221-222.
11. Hueston JT (1967). Limited fasciectomy in Dupuytren's contracture. Plastic and Reconstructive Surgery, 27: 569-581.
12. Kearon C, Hirsh J (1997). Management of anticoagulation before and after elective surgery. New England Journal of Medicine, 336: 1506-1511.
13. Kjeldal I, Nygaard HP (1988). Out-patient surgery for Dupuytren's disease under intravenous regional anaesthesia. Journal of Hand Surgery, 13B: 257-258.
14. Levine MN, Hirsh J, Gent M et al. (1995). Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis, 74: 606-611.
15. Lind SE (1991). The bleeding time does not predict surgical bleeding. Blood, 77: 2547-2552.
16. Mok CK, Boey J, Wang R et al. (1985). Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. Circulation, 72: 1059-1063.
17. Morris A, Elder MJ (2000). Warfarin therapy and cataract surgery. Clinical and Experimental Ophthalmology, 28: 419-422.
18. O'Shaughnessy DF, Tovey C, Miller ALC et al. (1998). Outpatient management of deep vein thrombosis. Journal of Accident and Emergency Medicine, 15: 292-293.
19. Otley CC, Fewkes JL, Frank W, Olbricht SM (1996). Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs. Archives of Dermatology, 132: 161-166.
20. Parkin B, Manners R (2000). Aspirin and warfarin therapy in oculoplastic surgery. British Journal of Ophthalmology, 84: 1426-1427.
21. Rose P, Bell D, Green ES et al. (2001). The outcome of ambulatory DVT management using a multidisciplinary approach. Clinics in Laboratory Haematology, 23: 301-306.
22. Schulman S, Rhedin AS, Lindmarker P et al. Duration of Anticoagulation Trial Study Group (1995). A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine, 332: 1661-1665.
23. Seyfer AE, Seaber AV, Dombrose FA, Urbaniak JR (1981). Coagulation changes in elective surgery and trauma. Annals of Surgery, 193: 210-213.
24. Turpie AGG, Chin BSP, Lip GYH (2002). Venous thromboembolism: treatment strategies. British Medical Journal, 325: 948-950.
25. Wahl MJ (1998). Dental surgery in anticoagulated patients. Archives of Internal Medicine, 158: 1610-1616.
26. Wahl MJ (2000). Myths of dental surgery in patients receiving anticoagulant therapy. Journal of the American Dental Association, 131: 77-81.
27. West SW, Otley CC, Nguyen TH et al. (2002). Cutaneous surgeons cannot predict blood-thinner status by intraoperative visual inspection. Plastic and Reconstructive Surgery, 110: 98-103.
28. White RH, McKittrick T, Hutchinson R, Twitchell J (1995). Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Annals of Internal Medicine, 122: 40-42.